According to a recent LinkedIn post from Gallant, the company is promoting a live Gallant U webinar focused on common questions about stem cell therapy within the veterinary community. The session, led by Director of Veterinary Affairs Rebecca Windsor, DVM, DACVIM, is scheduled for March 18 at 7:00 p.m. ET and is RACE-approved for one continuing education credit.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights that the format includes an in-depth discussion and a live Q&A segment, and encourages veterinary professionals to register via Gallant U. For investors, the initiative suggests ongoing efforts to position Gallant as an educational resource in regenerative veterinary medicine, which may support brand credibility, deepen engagement with veterinary practitioners, and potentially drive longer-term adoption of the company’s stem cell offerings.
By targeting continuing education and offering accredited content, the post implies a strategy to integrate Gallant more deeply into veterinarians’ professional development workflows. This approach could enhance the company’s influence over treatment preferences in the clinic setting, potentially strengthening its competitive position and supporting future revenue growth if increased awareness translates into higher utilization of its services.